MV Capital Management’s Biogen BIIB Stock Holding History

MV Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$33.9K	Sell	185 -9	-5%	-$1.66K	﹤0.01%	371
2025 Q4	$34.1K	Hold	194	–	–	﹤0.01%	356
2025 Q3	$27.2K	Buy	194 +14	+8%	+$1.89K	﹤0.01%	393
2025 Q2	$22.6K	Buy	180 +111	+161%	+$13.8K	﹤0.01%	426
2025 Q1	$9.44K	Buy	69 +6	+10%	+$858	﹤0.01%	527
2024 Q4	$9.63K	Sell	63 -9	-13%	-$1.52K	﹤0.01%	524
2024 Q3	$14K	Sell	72 -19	-21%	-$3.98K	﹤0.01%	488
2024 Q2	$21.1K	Buy	91 +28	+44%	+$6.08K	﹤0.01%	411
2024 Q1	$13.6K	Sell	63 -8	-11%	-$1.87K	﹤0.01%	480
2023 Q4	$18.4K	Buy	71 +7	+11%	+$1.72K	﹤0.01%	441
2023 Q3	$16.4K	Sell	64 -28	-30%	-$7.49K	﹤0.01%	427
2023 Q2	$26.2K	Buy	92 +17	+23%	+$5.06K	﹤0.01%	369
2023 Q1	$20.9K	Buy	75 +7	+10%	+$1.94K	﹤0.01%	394
2022 Q4	$18.8K	Buy	68 +11	+19%	+$3.11K	﹤0.01%	355
2022 Q3	$15K	Sell	57 -29	-34%	-$6.16K	﹤0.01%	379
2022 Q2	$18K	Buy	86 +13	+18%	+$2.66K	﹤0.01%	332
2022 Q1	$15K	Buy	73 +40	+121%	+$8.7K	﹤0.01%	371
2021 Q4	$8K	Sell	33 -15	-31%	-$3.86K	﹤0.01%	494
2021 Q3	$14K	Buy	48 +8	+20%	+$2.62K	﹤0.01%	367
2021 Q2	$14K	Buy	40 +20	+100%	+$6.06K	﹤0.01%	315
2021 Q1	$6K	Buy	20 +4	+25%	+$1.08K	﹤0.01%	270
2020 Q4	$4K	Sell	16 -30	-65%	-$7.74K	﹤0.01%	271
2020 Q3	$13K	Hold	46	–	–	﹤0.01%	210
2020 Q2	$12K	Sell	46 -7	-13%	-$2.1K	﹤0.01%	219
2020 Q1	$17K	Buy	53 +17	+47%	+$5.16K	﹤0.01%	192
2019 Q4	$11K	Buy	36 +6	+20%	+$1.67K	﹤0.01%	239
2019 Q3	$7K	Hold	30	–	–	﹤0.01%	256
2019 Q2	$7K	Hold	30	–	–	﹤0.01%	253
2019 Q1	$7K	Hold	30	–	–	﹤0.01%	255
2018 Q4	$9K	Hold	30	–	–	﹤0.01%	230
2018 Q3	$11K	Hold	30	–	–	﹤0.01%	236
2018 Q2	$9K	Hold	30	–	–	﹤0.01%	251
2018 Q1	$8K	Hold	30	–	–	﹤0.01%	257
2017 Q4	$10K	Hold	30	–	–	﹤0.01%	249
2017 Q3	$9K	Sell	30 -16	-35%	-$4.74K	﹤0.01%	253
2017 Q2	$12K	Hold	46	–	–	﹤0.01%	234
2017 Q1	$13K	Hold	46	–	–	﹤0.01%	225
2016 Q4	$13K	Hold	46	–	–	﹤0.01%	215
2016 Q3	$14K	Hold	46	–	–	0.01%	205
2016 Q2	$11K	Hold	46	–	–	﹤0.01%	217
2016 Q1	$12K	Hold	46	–	–	﹤0.01%	214
2015 Q4	$14K	Hold	46	–	–	0.01%	218
2015 Q3	$13K	Sell	46 -78	-63%	-$25.8K	0.01%	214
2015 Q2	$50K	Buy	124 +8	+7%	+$3.21K	0.02%	174
2015 Q1	$49K	Sell	116 -10	-8%	-$3.94K	0.02%	168
2014 Q4	$43K	Buy	+126	New	+$40.8K	0.02%	170

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MV Capital Management's BIIB Position: Q1 2026 in Review

MV Capital Management reduced its Biogen (BIIB) stake by 4.6% in Q1 2026, selling an estimated $1.66K and leaving 185 shares worth $33.9K. The position accounts for ﹤0.01% of the portfolio, ranked #371.

MV Capital Management first reported a position in BIIB in Q4 2014 and has held it in 46 quarters since. The position peaked at $50K in Q2 2015. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

MV Capital Management held 185 shares of Biogen worth $33.9K as of Q1 2026.
MV Capital Management sold 9 Biogen shares in Q1 2026, an estimated $1.66K.
Biogen made up ﹤0.01% of MV Capital Management's portfolio in Q1 2026, its #371 holding.
MV Capital Management first reported a position in Biogen in Q4 2014 and has held it in 46 quarters since.
MV Capital Management's Biogen position peaked at $50K in Q2 2015.
1,003 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on MV Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.